Cardio Diagnostics tests gain coverage at Atlas Healthcare Physicians network from May 2026

Cardio Diagnostics Holdings Inc.

Cardio Diagnostics Holdings Inc.

CDIO

0.00
  • Cardio Diagnostics struck a coverage deal with Atlas Healthcare Physicians, an independent physician association in Southern California.
  • AHP will cover Epi+Gen CHD and PrecisionCHD for members with prior authorization starting May 2026.
  • The agreement expands access across AHP’s managed-care network in Los Angeles and Orange County.
  • Epi+Gen CHD assesses three-year coronary heart disease event risk; PrecisionCHD supports CHD diagnosis with patient-specific molecular drivers.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardio Diagnostics Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202606240835BIZWIRE_USPR_____20260624_BW992562) on June 24, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.